Background. The Clinical and Laboratory Standards Institute (CLSI) recently elected to adjust the previous piperacillin susceptibility breakpoint of ≤64 μg/mL against Pseudomonas aeruginosa to ≤16 ...
Background. Emerging data suggest that vancomycin may be less effective against serious methicillin-resistant Staphylococcus aureus (MRSA) infections with minimum inhibitory concentration (MIC) values ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback